-
1
RBM47 is a novel immunotherapeutic target and prognostic biomarker in gliomas
Published 2025-01-01Subjects: Get full text
Article -
2
RBM47 promotes cell proliferation and immune evasion by upregulating PDIA6: a novel mechanism of pancreatic cancer progression
Published 2024-12-01Subjects: Get full text
Article